{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T17:47:44Z","timestamp":1790272064319,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"18","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T00:00:00Z","timestamp":1562630400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011102","name":"Seventh Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011102","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.bmc.2019.06.026","type":"journal-article","created":{"date-parts":[[2019,7,5]],"date-time":"2019-07-05T02:01:53Z","timestamp":1562292113000},"page":"4013-4029","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Alkynamide phthalazinones as a new class of TbrPDEB1 inhibitors (Part 2)"],"prefix":"10.1016","volume":"27","author":[{"given":"Erik","family":"de Heuvel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhimanyu K.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Boronat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert J.","family":"Kooistra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiffany","family":"van der Meer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Payman","family":"Sadek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoni R.","family":"Blaazer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan C.","family":"Shaner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daphne S.","family":"Bindels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Caljon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Maes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geert Jan","family":"Sterk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Siderius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Oberholzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iwan J.P.","family":"de Esch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David G.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob","family":"Leurs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2019.06.026_b0005","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0140-6736(09)60829-1","article-title":"Human african trypanosomiasis","volume":"375","author":"Brun","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.bmc.2019.06.026_b0010","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1016\/S0140-6736(17)31510-6","article-title":"Human African trypanosomiasis","volume":"390","author":"B\u00fcscher","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.bmc.2019.06.026_b0015","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1179\/2047773213Y.0000000105","article-title":"A current analysis of chemotherapy strategies for the treatment of human African trypanosomiasis","volume":"107","author":"Babokhov","year":"2013","journal-title":"Pathogens Global Health"},{"key":"10.1016\/j.bmc.2019.06.026_b0020","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1172\/JCI200421052","article-title":"Human African trypanosomiasis of the CNS: current issues and challenges","volume":"113","author":"Kennedy","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bmc.2019.06.026_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.pt.2018.08.006","article-title":"The long wait for a new drug for human african trypanosomiasis","author":"Baker","year":"2018","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.bmc.2019.06.026_b0030","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0304-4017(00)00427-1","article-title":"Drug resistance in pathogenic African trypanosomes: what hopes for the future?","volume":"96","author":"Anene","year":"2001","journal-title":"Vet Parasitol"},{"key":"10.1016\/j.bmc.2019.06.026_b0035","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.pt.2012.12.005","article-title":"Drug resistance in African trypanosomiasis: the melarsoprol and pentamidine story","volume":"29","author":"Baker","year":"2013","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.bmc.2019.06.026_b0040","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1042\/ETLS20170113","article-title":"Drug resistance in protozoan parasites","volume":"1","author":"de Koning","year":"2017","journal-title":"Emerg Top Life Sci"},{"key":"10.1016\/j.bmc.2019.06.026_b0045","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1128\/AAC.00122-14","article-title":"Independence from kinetoplast DNA maintenance and expression is associated with multidrug resistance in trypanosoma brucei in vitro","volume":"58","author":"Gould","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmc.2019.06.026_b0050","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1128\/AAC.00332-10","article-title":"Cross-resistance to nitro drugs and implications for treatment of human African trypanosomiasis","volume":"54","author":"Sokolova","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmc.2019.06.026_b0055","unstructured":"WHO, Trypanosomiasis, human African (sleeping sickness), https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/trypanosomiasis-human-african-(sleeping-sickness); 2018, Accessed on 03-02-2018."},{"key":"10.1016\/j.bmc.2019.06.026_b0060","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/cmdc.200700301","article-title":"N-myristoyltransferase: a prospective drug target for protozoan parasites","volume":"3","author":"Bowyer","year":"2008","journal-title":"Chem Med Chem"},{"key":"10.1016\/j.bmc.2019.06.026_b0065","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.molbiopara.2009.09.001","article-title":"Genetic validation of aldolase and glyceraldehyde-3-phosphate dehydrogenase as drug targets in Trypanosoma brucei","volume":"169","author":"Caceres","year":"2010","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.bmc.2019.06.026_b0070","doi-asserted-by":"crossref","first-page":"11280","DOI":"10.1021\/cr500197d","article-title":"Kinases as druggable targets in trypanosomatid protozoan parasites","volume":"114","author":"Merritt","year":"2014","journal-title":"Chem Rev"},{"key":"10.1016\/j.bmc.2019.06.026_b0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002492","article-title":"Exploring the Trypanosoma brucei Hsp83 potential as a target for structure guided drug design","volume":"7","author":"Pizarro","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.bmc.2019.06.026_b0080","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1096\/fj.06-6818com","article-title":"The Trypanosoma brucei cAMP phosphodiesterases TbrPDEB1 and TbrPDEB2: flagellar enzymes that are essential for parasite virulence","volume":"21","author":"Oberholzer","year":"2007","journal-title":"FASEB J"},{"key":"10.1016\/j.bmc.2019.06.026_b0085","doi-asserted-by":"crossref","first-page":"8188","DOI":"10.1021\/jm201148s","article-title":"Pharmacological validation of Trypanosoma brucei phosphodiesterases B1 and B2 as druggable targets for African sleeping sickness","volume":"54","author":"Bland","year":"2011","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2019.06.026_b0090","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/infdis\/jir857","article-title":"Pharmacological validation of Trypanosoma brucei phosphodiesterases as novel drug targets","volume":"206","author":"de Koning","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.bmc.2019.06.026_b0095","doi-asserted-by":"crossref","first-page":"8745","DOI":"10.1021\/jm301059b","article-title":"Catechol pyrazolinones as trypanocidals: fragment-based design, synthesis, and pharmacological evaluation of nanomolar inhibitors of trypanosomal phosphodiesterase B1","volume":"55","author":"Orrling","year":"2012","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2019.06.026_b0100","doi-asserted-by":"crossref","first-page":"S252","DOI":"10.1038\/sj.bjp.0706495","article-title":"Phosphodiesterase inhibitors","volume":"147","author":"Boswell-Smith","year":"2006","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bmc.2019.06.026_b0105","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0026-895X(25)10530-0","article-title":"Suppression of lipopolysaccharide-induced tumor necrosis factor-alpha generation from human peripheral blood monocytes by inhibitors of phosphodiesterase 4: interaction with stimulants of adenylyl cyclase","volume":"48","author":"Seldon","year":"1995","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bmc.2019.06.026_b0110","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0898-6568(96)00173-8","article-title":"Proposal for pharmacologically distinct conformers of PDE4 Cyclic AMP phosphodiesterases","volume":"9","author":"Souness","year":"1997","journal-title":"Cell Signal"},{"key":"10.1016\/j.bmc.2019.06.026_b0115","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.bmc.2016.02.032","article-title":"Synthesis and evaluation of analogs of the phenylpyridazinone NPD-001 as potent trypanosomal TbrPDEB1 phosphodiesterase inhibitors and in vitro trypanocidals","volume":"24","author":"Veerman","year":"2016","journal-title":"Biorg Med Chem"},{"key":"10.1016\/j.bmc.2019.06.026_b0120","doi-asserted-by":"crossref","first-page":"4084","DOI":"10.1016\/j.bmcl.2014.07.063","article-title":"Repurposing human PDE4 inhibitors for neglected tropical diseases: design, synthesis and evaluation of cilomilast analogues as Trypanosoma brucei PDEB1 inhibitors","volume":"24","author":"Amata","year":"2014","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2019.06.026_b0125","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jmedchem.7b01670","article-title":"Targeting a subpocket in Trypanosoma brucei phosphodiesterase B1 (TbrPDEB1) enables the structure-based discovery of selective inhibitors with trypanocidal activity","author":"Blaazer","year":"2018","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2019.06.026_b0130","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1021\/jm3017877","article-title":"Discovery of novel trypanosoma brucei phosphodiesterase B1 inhibitors by virtual screening against the unliganded TbrPDEB1 crystal structure","volume":"56","author":"Jansen","year":"2013","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2019.06.026_b0135","article-title":"Alkynamide phthalazinones as a new class of TbrPDEB1 inhibitors, part 1","author":"De Heuvel","year":"2019","journal-title":"Biorg Med Chem"},{"key":"10.1016\/j.bmc.2019.06.026_b0140","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1021\/ci800298z","article-title":"Empirical scoring functions for advanced protein\u2212ligand docking with PLANTS","volume":"49","author":"Korb","year":"2009","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.bmc.2019.06.026_b0145","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1021\/ci600342e","article-title":"Optimizing fragment and scaffold docking by use of molecular interaction fingerprints","volume":"47","author":"Marcou","year":"2007","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.bmc.2019.06.026_b0150","doi-asserted-by":"crossref","first-page":"28288","DOI":"10.1038\/srep28288","article-title":"Function-specific virtual screening for GPCR ligands using a combined scoring method","volume":"6","author":"Kooistra","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.bmc.2019.06.026_b0155","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1246\/cl.2006.22","article-title":"An efficient synthesis of \u03b2-aroylacrylic acid ethyl ester by the friedel-crafts reaction in the presence of diethyl sulfate","volume":"35","author":"Ken-ichi","year":"2006","journal-title":"Chem Lett"},{"key":"10.1016\/j.bmc.2019.06.026_b0160","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1016\/0040-4020(63)85029-2","article-title":"Configurational and conformational analysis: axial-axial and axial-equatorial coupling constants in six-membered ring compounds","volume":"19","author":"Huitric","year":"1963","journal-title":"Tetrahedron"},{"key":"10.1016\/j.bmc.2019.06.026_b0165","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01954-14","article-title":"Cyclic AMP regulates social behavior in african trypanosomes","volume":"6","author":"Oberholzer","year":"2015","journal-title":"mBio"},{"key":"10.1016\/j.bmc.2019.06.026_b0170","doi-asserted-by":"crossref","first-page":"7029","DOI":"10.1021\/acs.jmedchem.5b01813","article-title":"PDEStrIAn: a phosphodiesterase structure and ligand interaction annotated database as a tool for structure-based drug design","volume":"59","author":"Jansen","year":"2016","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2019.06.026_b0175","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1107\/S0907444913015308","article-title":"Decision making in xia2","volume":"69","author":"Winter","year":"2013","journal-title":"Acta Crystallographica Section D"},{"key":"10.1016\/j.bmc.2019.06.026_b0180","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1107\/S0907444911007773","article-title":"Data processing and analysis with the autoPROC toolbox","volume":"67","author":"Vonrhein","year":"2011","journal-title":"Acta Crystallographica Section D"},{"key":"10.1016\/j.bmc.2019.06.026_b0185","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1107\/S0907444909047374","article-title":"Integration, scaling, space-group assignment and post-refinement","volume":"66","author":"Kabsch","year":"2010","journal-title":"Acta Crystallographica Section D"},{"key":"10.1016\/j.bmc.2019.06.026_b0190","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1107\/S0907444913000061","article-title":"How good are my data and what is the resolution?","volume":"69","author":"Evans","year":"2013","journal-title":"Acta Crystallographica Section D"},{"key":"10.1016\/j.bmc.2019.06.026_b0195","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1107\/S0907444910048675","article-title":"iMOSFLM: a new graphical interface for diffraction-image processing with MOSFLM","volume":"67","author":"Battye","year":"2011","journal-title":"Acta Crystallographica Section D"},{"key":"10.1016\/j.bmc.2019.06.026_b0200","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1107\/S0907444910045749","article-title":"Overview of the CCP4 suite and current developments","volume":"67","author":"Winn","year":"2011","journal-title":"Acta Crystallographica Section D"},{"key":"10.1016\/j.bmc.2019.06.026_b0205","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1107\/S0021889807021206","article-title":"Phaser crystallographic software","volume":"40","author":"McCoy","year":"2007","journal-title":"J Appl Crystallogr"},{"key":"10.1016\/j.bmc.2019.06.026_b0210","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1107\/S0907444910007493","article-title":"Features and development of Coot","volume":"66","author":"Emsley","year":"2010","journal-title":"Acta Crystallographica Section D"},{"key":"10.1016\/j.bmc.2019.06.026_b0215","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1107\/S0907444911001314","article-title":"REFMAC5 for the refinement of macromolecular crystal structures","volume":"67","author":"Murshudov","year":"2011","journal-title":"Acta Crystallographica Section D"},{"key":"10.1016\/j.bmc.2019.06.026_b0220","unstructured":"The PyMOL Molecular Graphics System, Version 1.7, Schr\u00f6dinger, LLC."},{"key":"10.1016\/j.bmc.2019.06.026_b0225","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0166-6851(99)00002-X","article-title":"A tightly regulated inducible expression system for conditional gene knock-outs and dominant-negative genetics in Trypanosoma brucei","volume":"99","author":"Wirtz","year":"1999","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.bmc.2019.06.026_b0230","series-title":"Methods Cell Biol.","first-page":"21","article-title":"Chapter 2 \u2013 Approaches for Functional Analysis of Flagellar Proteins in African Trypanosomes","author":"Oberholzer","year":"2009"},{"key":"10.1016\/j.bmc.2019.06.026_b0235","doi-asserted-by":"crossref","first-page":"37215","DOI":"10.1074\/jbc.C400302200","article-title":"Novel single chain cAMP sensors for receptor-induced signal propagation","volume":"279","author":"Nikolaev","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2019.06.026_b0240","article-title":"Independent analysis of the flagellum surface and matrix proteomes provides insight into flagellum signaling in mammalian-infectious Trypanosoma brucei","volume":"10","author":"Oberholzer","year":"2011","journal-title":"Mole Cell Proteom: MCP"},{"key":"10.1016\/j.bmc.2019.06.026_b0245","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1083\/jcb.109.4.1695","article-title":"The major component of the paraflagellar rod of Trypanosoma brucei is a helical protein that is encoded by two identical, tandemly linked genes","volume":"109","author":"Schlaeppi","year":"1989","journal-title":"J Cell Biol"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089619307904?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089619307904?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T01:04:47Z","timestamp":1760835887000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089619307904"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":49,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S0968089619307904"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2019.06.026","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alkynamide phthalazinones as a new class of TbrPDEB1 inhibitors (Part 2)","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2019.06.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}